Singular Genomics Systems... (OMIC)
undefined
undefined%
At close: undefined
20.00
0.00%
After-hours Dec 13, 2024, 03:56 PM EST

Company Description

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine.

The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits.

It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution.

The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform.

Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California.

Singular Genomics Systems Inc.
Singular Genomics Systems Inc. logo
Country United States
IPO Date May 27, 2021
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 255
CEO Andrew Spaventa

Contact Details

Address:
10931 North Torrey Pines Road
La Jolla, California
United States
Website https://singulargenomics.com

Stock Details

Ticker Symbol OMIC
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001850906
CUSIP Number 82933R100
ISIN Number US82933R1005
Employer ID 81-2948451
SIC Code 3826

Key Executives

Name Position
Andrew Spaventa Founder, Chief Executive Officer, President & Chairperson of the Board
Dalen Meeter Chief Financial Officer
Dr. Jyotsna Ghai Ph.D. Chief Operating Officer
Dr. David L. Barker Ph.D. Founder, Member of Scientific Advisory Board & Independent Director
Dr. Eli N. Glezer Ph.D. Founder, Chief Scientific Officer & Chair of Scientific Advisory Board
Eric Stier Senior Vice President, General Counsel & Secretary
Jeff Bullard Head of Sales
Jorge Velarde Jr., MBA Chief Business Officer
Vincent Brancaccio Head of Human Resources

Latest SEC Filings

Date Type Title
Nov 22, 2024 SC 13D/A [Amend] Filing
Nov 13, 2024 4 Filing
Nov 13, 2024 4 Filing
Nov 13, 2024 4 Filing
Nov 13, 2024 4 Filing
Nov 12, 2024 10-Q Quarterly Report
Nov 12, 2024 8-K Current Report
Nov 05, 2024 SC 13D Filing
Nov 04, 2024 8-K Current Report
Nov 01, 2024 SC 13D/A [Amend] Filing